Robo2 mRNA is detected in the dorsally-projecting motor neurons aCC and RP2, labeled by RN2Gal4>UAS-TauMycGFP (red) during the early stages of motor axon pathfinding (Stage 13).
During Stages 15-17, when the ISN targets dorsal muscle regions, robo2 is no longer enriched in aCC/RP2. B: Stage 16 embryo, dorsal is up. Robo2 is expressed in the ventral muscles 7 and 6, which are labeled in green in the cartoon. Df(2L)ED108 (Ryder et al., 2007) ; robo2 robo2 , robo2 robo1 , robo2 robo3 , robo2 robo2-1 , robo2 robo1-2 (Spitzweck et al., 2010) ; robo2 F (gift from L. Zipursky). Robo2 F is a loss of function allele generated by EMS mutagenesis on the robo3 3 chromosome. The following transgenes were used: Wheeler et al., 2006) ; -Hb9 (Broihier et al., 2002); isletH-tau-myc (Thor et al., 1997); lim3A-tau-myc (Thor et al., 1999); lim3b-gal4 (Certel et al., 2004) ; [UAS-HARobo1-2].T39, .T6, .T1, .T15 (Evans et al., 2010) Embryos were genotyped using a combination of marked balancer chromosomes or the presence of tagged transgenes.
UAS

Immunostaining
Embryo fixation and staining were performed as described (Kidd et al., 1998) . The following antibodies were used: mouse MAb 1D4/Fasciclin II [Developmental Studies Hybridoma Bank (DSHB); 1:100], mouse anti-ßgal (DSHB; 1:150), mouse anti-HA (Covance #MMS-101P; 1:250), rabbit anti-GFP (Invitrogen #A11122; 1:500), rabbit anti-c-Myc (Sigma #C3956; 1:500), chick anti-ßgal (Abcam #9361; 1:1000), guinea pig anti-Hb9 (gift from J. Skeath; 1:1000), Cy3 goat anti-mouse (Jackson #115-165-003; 1:1000), Alexa-488 goat anti-rabbit (Molecular Probes #A11008; 1:500), Cy3 goat anti-chick (Abcam #97145; 1:500), Alexa-647 goat anti-Guinea Pig (Molecular Probes #A-21450; 1:500).
Fluorescent in situ quantification
Fluorescent in situ hybridization was performed as described (Labrador et al., 2005) . Max projections were obtained for embryos from the same collection. A region of interest (ROI) was generated around the RP cell bodies in ImageJ software, using the islet-tau-myc staining as a reference. Total fluorescence intensity above a set threshold was obtained for each channel by multiplying the area of the ROI by the average fluorescence intensity within the ROI above the threshold. Relative fluorescence intensity of robo2 mRNA was calculated as absolute robo2 mRNA fluorescence intensity divided by absolute myc fluorescence intensity.
Phenotypic quantification
Phenotypes were scored using Volocity imaging software. For scoring robo2 and robo3 expression, if the cell body of a neuron could be detected by the in situ signal, that neuron was scored as positive. RP3 neurons were identified by using islet-tau-myc and their position; ventral apterous neurons were identified by using apGal4 and their position; MP1 neurons were identified by using C544-Gal4, FasII, and their position. For motor axon phenotypes, hemisegments in which a FasII+ axon could not be detected between the cleft of ventral muscles 6 and 7 were scored as lacking the muscle 6/7 innervation. A2-A6 were scored in late Stage 17 embryos. For Hb9Gal4+ axon phenotypes, the presence of the medial, intermediate, or lateral hb9gal4+ axon bundles was scored for hemisegments in A1-A8 in Stage 17 embryos. If a bundle could not be detected or was visibly shifted to another lateral zone, it was scored as absent. For apterous lateral shift phenotypes, if a hemisegment contained an apterous axon that projected along the intermediate or lateral FasII tracts, it was scored as shifted. A1-A8 were scored in Stage 17 embryos. For MP1 axon phenotypes, the lateral position of MP1 axons was scored relative to the FasII pathways. A1-A7 were scored in Stage 16-17 embryos. For statistical analysis, comparisons were made between genotypes using the Student's t-test or Fisher's exact test, as indicated in the figure legends. Embryos were scored blind to genotype when possible.
